Salt, sweat, and unclear? Diaphoresis and hypernatremia in end-stage kidney disease: Answers

Pediatr Nephrol. 2018 Feb;33(2):253-254. doi: 10.1007/s00467-017-3668-6. Epub 2017 Apr 27.

Daniella Levy Erez^{1

2}, Lawrence Copelovitch^{3

4}, Michele Denburg^{3

4}

¹ Division of Nephrology, The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA, 19104-4399, USA. levy.erez.daniella@gmail.com.
² Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. levy.erez.daniella@gmail.com.
³ Division of Nephrology, The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA, 19104-4399, USA.
⁴ Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

No abstract available

Keywords: Bethanechol; Diaphoresis; End-stage kidney disease; Hypernatremia; Muscarinic toxicity.

Publication types